Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4338464

CC(C)(CO)CNC(=O)c1nc(-c2ccc(F)cc2)n2ccccc12.O=C(O)C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.47
HTR4 Q13639 5/20 0.43
CYP3A4 P08684 2/20 0.40
EGLN2 Q96KS0 1/20 0.39
HPGD P15428 2/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CFTR P13569 3/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
GUCY1B2 O75343 1/20 0.37
GUCY1A2 P33402 1/20 0.37
GUCY1A1 Q02108 1/20 0.37
GUCY1B1 Q02153 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13578105 0.96 CNR2 (0.50) CNR2HTR4CYP3A4EGLN2HPGD
Trifluoroacetic Acid SCHEMBL4320267 0.91 CNR2 (0.57) CNR2HTR4CYP3A4EGLN2HPGD
SCHEMBL13578093 0.87 CNR2 (0.61) CNR2HTR4CYP3A4EGLN2HPGD
Trifluoroacetic Acid SCHEMBL4326435 0.84 ALDH1A1 (0.50) CNR2HPGDSMN1; SMN2KDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL4321817 0.84 KDM4E (0.47) CNR2HPGDSMN1; SMN2KDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL4327011 0.81 TP53 (0.44) CNR2HPGDPOLBALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL4341463 0.81 SMN1; SMN2 (0.40) CNR2HPGDPOLBMAPK1SMN1; SMN2
SCHEMBL4329757 0.80 CNR2 (0.47) CNR2HTR4L3MBTL1KDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL4331110 0.80 CNR2 (0.54) CNR2HTR4CYP3A4HPGDPOLB
Trifluoroacetic Acid SCHEMBL4326117 0.80 TP53 (0.49) CNR2SMN1; SMN2L3MBTL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325936-A1 IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES MERCK & CO., INC. 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325936-A1 IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES CNR2, CNR1, TRPV1 CNR2 1/4885HTR4 254/4885CYP3A4 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.